Efficacy and safety of nintedanib for older adults with idiopathic pulmonary fibrosis or progressive fibrosing interstitial lung disease: A multicenter retrospective study in Japan
{{output}}
Background: Nintedanib is widely used for idiopathic pulmonary fibrosis (IPF) and progressive fibrosing interstitial lung disease (PF-ILD). However, real-world data regarding its efficacy and safety in patients aged 75 years or o... ...
